SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

HC Wainwright & Co. Initiates Coverage On Avadel Pharmaceuticals with Buy Rating, Announces Price Target of $15

HC Wainwright & Co. analyst Oren Livnat initiates coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and announces Price Target of $15.

Benzinga · -
HC Wainwright & Co. analyst Oren Livnat initiates coverage on Avadel Pharmaceuticals (NASDAQ: AVDL) with a Buy rating and announces Price Target of $15.